SCHEDULE: ING Groep Discloses 6.47% Stake in NEOGEN CORP

ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have jointly disclosed a beneficial ownership of 6.47% in NEOGEN CORP's common stock.

Summary

• ING Groep N.V. and ING Capital Markets LLC reported beneficial ownership of 14,060,900 shares of NEOGEN CORP common stock.
• This represents approximately 6.47% of NEOGEN CORP's outstanding common stock.
• The ownership is shared, with both entities having shared voting and dispositive power over the 14,060,900 shares.
• The percentage is based on 217,298,626 shares of common stock outstanding as of August 31, 2025, as reported in NEOGEN CORP's Form 10-Q.
• The filing was made under Rule 13d-1(b), indicating an institutional investor.
• The reporting persons certified that the securities were not acquired for the purpose of changing or influencing control of NEOGEN CORP.

Sentiment

Score: 7

Explanation: The disclosure of a significant stake by a major financial institution like ING Groep can be viewed positively as a vote of confidence in NEOGEN CORP, although the filing itself is purely factual and does not contain performance data.

Positives

• A significant institutional investor, ING Groep, has taken a substantial stake in NEOGEN CORP, potentially signaling confidence in the company's long-term prospects.
• The filing explicitly states that the securities were not acquired for the purpose of changing or influencing control, which may reduce concerns about activist investor actions.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: May view the significant institutional investment as a positive signal, potentially increasing confidence in the stock.
• Management: The certification that the stake is not for control purposes suggests no immediate threat of activist intervention.

Next Steps

• NEOGEN CORP will continue its operations.
• ING Groep N.V. and ING Capital Markets LLC will continue to hold or adjust their stake in NEOGEN CORP.
• Future Schedule 13D/G filings would be required if ownership changes significantly (e.g., crosses 10% or if intent changes to influence control).

Key Dates

Keywords

NEOGEN CORP, ING Groep, ING Capital Markets, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Stake, SEC Filing